You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunization schedule

Showing 1 - 25 of 3,626
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Quadrivalent Influenza Vaccine Immunization Schedule for

Completed
  • GCP
  • Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
  • Jinan, Shandong, China
    Kou Zengqiang
Oct 17, 2023

Childhood Cancer, Multiple Diseases Trial in New York (Immunization Schedule patients <7 years., Immunization Schedule patients

Active, not recruiting
  • Childhood Cancer
  • Multiple Diseases
  • Immunization Schedule patients <7 years.
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
Aug 9, 2022

SARS-CoV2 Infection Trial in Mile (SARS-CoV-2 Vaccine, Inactivated (Vero Cell))

Recruiting
  • SARS-CoV2 Infection
  • SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
  • Mile, Yunnan, China
    Mile City Centers for Disease Control and Prevention
Feb 14, 2022

SARS-CoV-2 Infection Trial in Anning (SARS-CoV-2 Vaccine, Inactivated (Vero Cell))

Recruiting
  • SARS-CoV-2 Infection
  • SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
  • Anning, Yunnan, China
    Anning First People's Hospital
Feb 14, 2022

Rabies Trial in Xiangyang (Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried)

Not yet recruiting
  • Rabies
  • Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried
  • Xiangyang, Hubei, China
    Gucheng Center for Disease Control and Prevention
Nov 19, 2023

Hepatitis B Trial in Bobo-Dioulasso (birth dose vaccination against hepatitis B strategy)

Recruiting
  • Hepatitis B
  • birth dose vaccination against hepatitis B strategy
  • Bobo-Dioulasso, Dafra, Burkina Faso
  • +1 more
Apr 19, 2022

Covid19 Trial in Xinxiang (3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated, 3-doses schedule 2 of COVID-19

Recruiting
  • Covid19
  • 3-doses schedule 1 of COVID-19 Vaccine (Vero Cell), Inactivated
  • +3 more
  • Xinxiang, Henan, China
    Yanjin County Center for Disease Control and Prevention
Jun 15, 2022

Immunization Programs Trial in Danville (Reminder)

Completed
  • Immunization Programs
  • Reminder
  • Danville, Pennsylvania
    Geisinger
Nov 21, 2022

Hepatitis B, Immunization; Infection Trial in Hyderabad (recombinant hepatitis B vaccine ENGERIX 10 micrograms (µ gm),, Short

Completed
  • Hepatitis B
  • Immunization; Infection
  • recombinant hepatitis B vaccine ENGERIX 10 micrograms (µ gm),
  • Short text messages and calls to parents for compliance to routine immunization schedule
  • Hyderabad, Pakistan
    Countess Dufferin Fund (CDF) Hospital
Apr 28, 2021

Invasive Pneumococcal Disease, Protection Against, Streptococcus Pneumoniae Infection Trial in Vancouver (PCV13)

Active, not recruiting
  • Invasive Pneumococcal Disease, Protection Against
  • Streptococcus Pneumoniae Infection
  • PCV13
  • Vancouver, British Columbia, Canada
    Vaccine Evaluation Center (University of BC at Children's Hospit
May 17, 2022

Healthy Trial in Dasmarinas, Manila (sIPV, cIPV)

Completed
  • Healthy
  • sIPV
  • cIPV
  • Dasmarinas, Philippines
  • +2 more
Aug 6, 2020

COVID-19 Trial in Canada (mRNA-1273 SARS-CoV-2 vaccine, BNT162b2, ChAdOx1-S [recombinant])

Recruiting
  • COVID-19
  • mRNA-1273 SARS-CoV-2 vaccine
  • +4 more
  • Edmonton, Alberta, Canada
  • +7 more
Mar 7, 2022

Immunization; Infection, Educational Problems, Information Seeking Behavior Trial in Jada (Information Provision)

Completed
  • Immunization; Infection
  • +2 more
  • Information Provision
  • Jada, Adamawa, Nigeria
    Jada Local Government Primary Health Care Development Agency
Jul 11, 2020

Poliomyelitis Trial in Kathmandu (Inactivated Polio Vaccine (IPV))

Completed
  • Poliomyelitis
  • Inactivated Polio Vaccine (IPV)
  • Kathmandu, Nepal
  • +2 more
Apr 5, 2020

Lyme Borreliosis, Nervous System Trial in La Mesa, Lincoln, Ghent (VLA15 with Alum, VLA15 without Alum)

Completed
  • Lyme Borreliosis, Nervous System
  • VLA15 with Alum
  • VLA15 without Alum
  • La Mesa, California
  • +2 more
Dec 16, 2022

COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)

Active, not recruiting
  • COVID-19
  • Inactivated COVID-19 Vaccine
  • Weihai, Shandong, China
    Rushan City Center for Disease Control and Prevention
Jul 11, 2022

Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel

Not yet recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • (no location specified)
Sep 5, 2023

Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Hepatitis E Virus Infection Trial in Hanzhou

Active, not recruiting
  • Human Papilloma Virus Infection Type 16
  • +2 more
  • Cecolin
  • Hecolin
  • Hanzhou, Zhejiang, China
    Zhejiang Provincial Center for Disease Control and Prevention
Jun 8, 2022

Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent

Not yet recruiting
  • Seasonal Influenza
  • Quadrivalent influenza vaccine(0.25ml)
  • +3 more
  • Lu'an, Anhui, China
  • +4 more
Sep 15, 2023

Influenza and Pneumonia Trial in Taizhou (Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal

Completed
  • Influenza and Pneumonia
  • Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
  • Separate vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
  • Taizhou, Jiangsu, China
  • +3 more
Jul 20, 2022

COVID19 Trial in Guangzhou (Recombinant SARS-CoV-2 Fusion Protein Vaccine)

Completed
  • COVID19
  • Recombinant SARS-CoV-2 Fusion Protein Vaccine
  • Guangzhou, Guangdong, China
    Guangdong Provincial Center for Disease Control and Prevention
Feb 10, 2022

COVID-19 Trial in Nanjing (One dose group, Two doses group, Aged 18-59 years)

Not yet recruiting
  • COVID-19
  • One dose group
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Dec 25, 2022

COVID-19 Trial in Hangzhou (Omicron COVID-19 Vaccine (Vero Cell), Inactivated)

Recruiting
  • COVID-19
  • Omicron COVID-19 Vaccine (Vero Cell), Inactivated
  • Hangzhou, Zhejiang, China
    Shulan (hangzhou) Hospital
May 5, 2022

Japanese Encephalitis, Vaccine Preventable Disease, Vaccine Reaction Trial in Lishui, Quzhou, Wenzhou (Japanese Encephalitis

Active, not recruiting
  • Japanese Encephalitis
  • +2 more
  • Japanese Encephalitis Vaccine (Vero Cell), Inactivated;
  • No prospective interventions
  • Lishui, Zhejiang, China
  • +2 more
Nov 13, 2022

Seasonal Influenza Trial in Huai'an, Lianyungang, Yancheng (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza

Recruiting
  • Seasonal Influenza
  • Quadrivalent influenza vaccine(0.25ml)
  • +3 more
  • Huai'an, Jiangsu, China
  • +3 more
Aug 9, 2022